ASP Isotopes (NASDAQ:ASPI) Shares Gap Down – Should You Sell?

ASP Isotopes Inc. (NASDAQ:ASPI) gapped down before the market opened on Tuesday . The stock had previously closed at $7.52, but opened at $6.51. ASP Isotopes shares last traded at $6.75, with a volume of 7,549,913 shares changing hands.

ASP Isotopes Stock Performance

The company’s 50-day simple moving average is $5.28 and its 200 day simple moving average is $5.43. The stock has a market cap of $507.42 million, a P/E ratio of -10.89 and a beta of 3.40. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80.

Insider Activity

In other news, COO Robert Ainscow sold 66,668 shares of the company’s stock in a transaction dated Thursday, April 17th. The shares were sold at an average price of $5.62, for a total transaction of $374,674.16. Following the completion of the sale, the chief operating officer now owns 1,419,992 shares of the company’s stock, valued at $7,980,355.04. This represents a 4.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Paul Elliot Mann sold 316,667 shares of the stock in a transaction that occurred on Tuesday, April 15th. The stock was sold at an average price of $5.75, for a total transaction of $1,820,835.25. Following the completion of the transaction, the chief executive officer now owns 7,948,787 shares in the company, valued at $45,705,525.25. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 766,667 shares of company stock valued at $4,358,502. 21.40% of the stock is currently owned by company insiders.

Institutional Trading of ASP Isotopes

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ASPI. Hanson & Doremus Investment Management bought a new stake in shares of ASP Isotopes during the 4th quarter valued at $27,000. BNP Paribas Financial Markets bought a new stake in ASP Isotopes during the fourth quarter valued at about $34,000. SBI Securities Co. Ltd. grew its holdings in ASP Isotopes by 84.8% during the first quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company’s stock valued at $44,000 after purchasing an additional 4,299 shares during the period. Avantax Advisory Services Inc. purchased a new stake in ASP Isotopes in the fourth quarter worth about $45,000. Finally, Russell Investments Group Ltd. raised its stake in shares of ASP Isotopes by 56.3% in the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company’s stock worth $46,000 after buying an additional 3,682 shares during the period. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.